Food and Drug Administration

Upside’s cell-cultured chicken is first to receive FDA blessing for its production method

The FDA sent a letter to Upside Foods concluding that it had “no further questions” related to its cell-based, chicken-making process.

FDA won’t require lengthy clinical trials for COVID-19 boosters

Future COVID-19 vaccine boosters won’t have to go through a traditional, lengthy clinical trial process to attain emergency use authorization in the U.S., according to a report in Reuters. An ag

Juul can keep selling vaping products in the US for now

A federal appeals court froze the FDA’s ban on Juul products Friday after the company sought an emergency administrative stay. On Thursday, the U.S. regulator took sweeping action against the e-

FDA clears COVID-19 vaccines for children under 5

The U.S. Food and Drug Administration has authorized use of the COVID-19 vaccines from Pfizer and BioNTech, and from Moderna, for kids between six months and five years of age. The FDA’s decisio

The FDA should regulate Instagram’s algorithm as a drug

Instagram’s unwillingness to do what is right is a clarion call for regulation: The FDA must assert its codified right to regulate the algorithm powering the drug of Instagram.

The health data transparency movement is birthing a new generation of startups

The recent movement toward data transparency is birthing a new generation of innovation and startups that could ultimately make healthcare better and more transparent for all of us.

Vibrant raises $7.5M for a drug-free mechanical pill to treat constipation

Vibrant, a medical technology company that’s developed a disposable vibrating pill to treat chronic constipation, today announced its Series E for $7.5 million. The company is based in Tel Aviv and

Has a startup finally found one of food science’s holy grails with its healthy sugar substitute?

A little less than three years ago at the Computer Science Museum in Mountain View, California, the founders of a young company hailing from Cambridge, England addressed a crowd of celebrities, invest

LabCorp COVID-19 test kit has just been approved for sale over-the-counter

LabCorp has now become the first company to receive approval to sell its COVID-19 test kit over-the-counter without a prescription, according to a statement from the company. One of the largest diagno

Palantir will soon help the FDA evaluate drugs, including COVID-19 treatments

Palantir’s push into federal health work continues. The data analytics company just picked up a new U.S. Food and Drug Administration contract which will span three years for a total of $44.4 mi

Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19

Resilience, a new biopharmaceutical company backed by $800 million in financing from investors including ARCH Venture Partners and 8VC, has emerged from stealth to transform the way that drugs and the

Ro makes the weight loss product Plenity commercially available to everyone in the US

In what could be the first step in the development of a significant new line of business for the telemedicine prescription provider Ro, the company is finally announcing the general commercial availab

Sight Diagnostics raises $71M Series D for its blood analyzer

Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch Disrupti

Using population health analysis to improve patient care brings Sema4 a $1.1 billion valuation

Sema4, the Stamford, Connecticut-based digital healthcare company now worth just over $1 billion, takes its name from the system of sending messages via code using flags. And like its namesake, Sema4

FDA revokes emergency authorization for chloroquine and hydroxychloroquine in COVID-19 treatment

The U.S. Food and Drug Administration (FDA) has revoked an emergency use authorization (EUA) that it previously issued for chloroquine and hydroxychloroquine, two anti-malarial drugs also used in the

Cue Health’s portable, fast COVID-19 test gains FDA emergency approval

Fresh off a $100 million Series C funding round, molecular diagnostics startup Cue Health has more good news — it has received an Emergency Use Authorization (EUA) for its rapid, point-of-care COVID

Mammoth Biosciences partners with GSK to develop handheld CRISPR-based COVID-19 test

California-based Mammoth Biosciences has signed a powerful partner for its development of a CRISPR-based test for COVID-19, which would aim to deliver accurate, fast results using a handheld, disposab

Everlywell gains first FDA authorization for a standalone, at-home, COVID-19 test sample collection kit

Everlywell was one of the first startups to announce that it was working on a self-administered, at-home COVID-19 diagnostic kit, but it initially sought out to ship kits before regulators made clear

FDA authorizes a ventilator developed by NASA’s JPL for emergency use in COVID-19 treatment

The U.S. Food and Drug Administration (FDA) has authorized for emergency use as outlined in the agency’s COVID-19 guidelines a new ventilator designed by engineers working at NASA’s Jet Pr

FDA reiterates risks of antimalarial drug use for COVID-19, as study into efficacy ends early due to deaths

The U.S. Food and Drug Administration (FDA) has issued a new warning about the known side effects of hydroxychloroquine and chloroquine, two antimalarial drugs (also used in the treatment of chronic r
Load More